Mesenchymal stem/stromal cells as adjuvant therapy in COVID-19-associated acute lung injury and cytokine storm: Importance of cell identification

Theoretically, mesenchymal stem cells (MSCs) are very promising as adjuvant therapy to alleviate coronavirus disease 2019 (COVID-19)-associated acute lung injury and cytokine storm. Several published studies, which used MSCs to alleviate COVID-19-associated acute lung injury and cytokine storm, repo...

Descripción completa

Detalles Bibliográficos
Autor principal: Pawitan, Jeanne Adiwinata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968215/
https://www.ncbi.nlm.nih.gov/pubmed/35432737
http://dx.doi.org/10.4252/wjsc.v14.i3.264
_version_ 1784679001988530176
author Pawitan, Jeanne Adiwinata
author_facet Pawitan, Jeanne Adiwinata
author_sort Pawitan, Jeanne Adiwinata
collection PubMed
description Theoretically, mesenchymal stem cells (MSCs) are very promising as adjuvant therapy to alleviate coronavirus disease 2019 (COVID-19)-associated acute lung injury and cytokine storm. Several published studies, which used MSCs to alleviate COVID-19-associated acute lung injury and cytokine storm, reported promising results. However, the evidence came from a case report, case series, and clinical trials with a limited number of participants. Therefore, more studies are needed to get robust proof of MSC beneficial effects.
format Online
Article
Text
id pubmed-8968215
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-89682152022-04-14 Mesenchymal stem/stromal cells as adjuvant therapy in COVID-19-associated acute lung injury and cytokine storm: Importance of cell identification Pawitan, Jeanne Adiwinata World J Stem Cells Letter to the Editor Theoretically, mesenchymal stem cells (MSCs) are very promising as adjuvant therapy to alleviate coronavirus disease 2019 (COVID-19)-associated acute lung injury and cytokine storm. Several published studies, which used MSCs to alleviate COVID-19-associated acute lung injury and cytokine storm, reported promising results. However, the evidence came from a case report, case series, and clinical trials with a limited number of participants. Therefore, more studies are needed to get robust proof of MSC beneficial effects. Baishideng Publishing Group Inc 2022-03-26 2022-03-26 /pmc/articles/PMC8968215/ /pubmed/35432737 http://dx.doi.org/10.4252/wjsc.v14.i3.264 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Letter to the Editor
Pawitan, Jeanne Adiwinata
Mesenchymal stem/stromal cells as adjuvant therapy in COVID-19-associated acute lung injury and cytokine storm: Importance of cell identification
title Mesenchymal stem/stromal cells as adjuvant therapy in COVID-19-associated acute lung injury and cytokine storm: Importance of cell identification
title_full Mesenchymal stem/stromal cells as adjuvant therapy in COVID-19-associated acute lung injury and cytokine storm: Importance of cell identification
title_fullStr Mesenchymal stem/stromal cells as adjuvant therapy in COVID-19-associated acute lung injury and cytokine storm: Importance of cell identification
title_full_unstemmed Mesenchymal stem/stromal cells as adjuvant therapy in COVID-19-associated acute lung injury and cytokine storm: Importance of cell identification
title_short Mesenchymal stem/stromal cells as adjuvant therapy in COVID-19-associated acute lung injury and cytokine storm: Importance of cell identification
title_sort mesenchymal stem/stromal cells as adjuvant therapy in covid-19-associated acute lung injury and cytokine storm: importance of cell identification
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968215/
https://www.ncbi.nlm.nih.gov/pubmed/35432737
http://dx.doi.org/10.4252/wjsc.v14.i3.264
work_keys_str_mv AT pawitanjeanneadiwinata mesenchymalstemstromalcellsasadjuvanttherapyincovid19associatedacutelunginjuryandcytokinestormimportanceofcellidentification

Ejemplares similares